{
  "id": 4582,
  "url": "https://nnemf.org/research/4582-extremely-low-frequency-electromagnetic-fields-induce-neural-differentiation",
  "title": "Extremely low-frequency electromagnetic fields induce neural differentiation in bone marrow derived mesenchymal stem cells.",
  "authors": [
    "Hyun-Jung Kim",
    "Jessica Jung",
    "Jee-Hye Park",
    "Jin-Hee Kim",
    "Kyung-Nam Ko",
    "Chan-Wha Kim"
  ],
  "journal": "Experimental biology and medicine (Maywood, N.J.)",
  "year": "2013",
  "doi": "10.1177/1535370213497173",
  "pmid": "23970408",
  "abstract": "Extremely low-frequency electromagnetic fields (ELF-EMF) affect numerous biological functions such as gene expression, cell fate determination and even cell differentiation. To investigate the correlation between ELF-EMF exposure and differentiation, bone marrow derived mesenchymal stem cells (BM-MSCs) were subjected to a 50-Hz electromagnetic field during in vitro expansion. The influence of ELF-EMF on BM-MSCs was analysed by a range of different analytical methods to understand its role in the enhancement of neural differentiation. ELF-EMF exposure significantly decreased the rate of proliferation, which in turn caused an increase in neuronal differentiation. The ELF-EMF-treated cells showed increased levels of neuronal differentiation marker (MAP2), while early neuronal marker (Nestin) was down-regulated. In addition, eight differentially expressed proteins were detected in two-dimensional electrophoresis maps, and were identified using ESI-Q-TOF LC/MS/MS. Among them, ferritin light chain, thioredoxin-dependent peroxide reductase, and tubulin β-6 chain were up-regulated in the ELF-EMF-stimulated group. Ferritin and thioredoxin-dependent peroxide reductase are involved in a wide variety of functions, including Ca(2+) regulation, which is a critical component of neurodegeneration. We also observed that the intracellular Ca(2+) content was significantly elevated after ELF-EMF exposure, which strengthens the modulatory role of ferritin and thioredoxin-dependent peroxide reductase, during differentiation. Notably, western blot analysis indicated significantly increased expression of the ferritin light chain in the ELF-EMF-stimulated group (0.60 vs. 1.08; P < 0.01). These proteins may help understand the effect of ELF-EMF stimulation on BM-MSCs during neural differentiation and its potential use as a clinically therapeutic option for treating neurodegenerative diseases.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Bone marrow derived mesenchymal stem cells (BM-MSCs)",
    "sampleSize": "—",
    "exposure": "ELF · 0.05 MHz · during in vitro expansion",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "BM-MSCs exposed to a 50-Hz ELF-EMF during in vitro expansion showed a significantly decreased proliferation rate and an increase in neuronal differentiation. ELF-EMF-treated cells had increased MAP2 and down-regulated Nestin, with elevated intracellular Ca(2+) and increased ferritin light chain expression (0.60 vs. 1.08; P<0.01).",
    "outcomes": [
      "Cell proliferation rate",
      "Neural/neuronal differentiation",
      "Expression of neuronal differentiation marker MAP2",
      "Expression of early neuronal marker Nestin",
      "Differentially expressed proteins (2D electrophoresis",
      "ESI-Q-TOF LC/MS/MS identification)",
      "Intracellular Ca(2+) content",
      "Ferritin light chain expression (western blot)"
    ],
    "limitations": [
      "In vitro study",
      "findings may not translate to in vivo or clinical outcomes",
      "Exposure parameters beyond frequency (e.g.",
      "field strength) not reported in abstract",
      "Sample size not reported in abstract"
    ],
    "keywords": [
      "ELF-EMF",
      "50 Hz",
      "mesenchymal stem cells",
      "BM-MSCs",
      "neural differentiation",
      "neuronal markers",
      "MAP2",
      "Nestin",
      "proteomics",
      "ferritin light chain",
      "thioredoxin-dependent peroxide reductase",
      "intracellular calcium"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": null,\n    \"frequency_mhz\": 0.05,\n    \"sar_wkg\": null,\n    \"duration\": \"during in vitro expansion\"\n  },\n  \"population\": \"Bone marrow derived mesenchymal stem cells (BM-MSCs)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Cell proliferation rate\",\n    \"Neural/neuronal differentiation\",\n    \"Expression of neuronal differentiation marker MAP2\",\n    \"Expression of early neuronal marker Nestin\",\n    \"Differentially expressed proteins (2D electrophoresis; ESI-Q-TOF LC/MS/MS identification)\",\n    \"Intracellular Ca(2+) content\",\n    \"Ferritin light chain expression (western blot)\"\n  ],\n  \"main_findings\": \"BM-MSCs exposed to a 50-Hz ELF-EMF during in vitro expansion showed a significantly decreased proliferation rate and an increase in neuronal differentiation. ELF-EMF-treated cells had increased MAP2 and down-regulated Nestin, with elevated intracellular Ca(2+) and increased ferritin light chain expression (0.60 vs. 1.08; P<0.01).\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"In vitro study; findings may not translate to in vivo or clinical outcomes\",\n    \"Exposure parameters beyond frequency (e.g., field strength) not reported in abstract\",\n    \"Sample size not reported in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"ELF-EMF\",\n    \"50 Hz\",\n    \"mesenchymal stem cells\",\n    \"BM-MSCs\",\n    \"neural differentiation\",\n    \"neuronal markers\",\n    \"MAP2\",\n    \"Nestin\",\n    \"proteomics\",\n    \"ferritin light chain\",\n    \"thioredoxin-dependent peroxide reductase\",\n    \"intracellular calcium\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/23970408/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4582",
  "updated": "2026-02-14 08:00:28"
}